Novack David F's Form 4 filing
Dynavax Technologies Corp (DVAX) · filed Nov 10, 2022
- Accession no.
- 0001209191-22-056399
- Filed
- Nov 10, 2022
- Trade date
- Aug 15-Nov 8, 2022
- Filing delay
- 87 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $651.0K. It was filed 87 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novack David FCIK 0001573072 | Officer (President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock | AGrant or awardAcquired | +1,057 | $10.29 | +$10,876.53 | 54,270 | Direct | |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −52,204 | $12.47F2 | −$650,983.88 | 2,066 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $12.31 to $12.62; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
Referenced by the price of 1 transaction in Table I.